$85.9 Million is the total value of Soleus Capital Management, L.P.'s 48 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 75.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EPIX | Buy | ESSA PHARMA INC | $8,322,000 | -7.4% | 2,080,421 | +27.3% | 9.68% | +11.7% |
| GRFS | Sell | GRIFOLS S Asp adr rep b nvt | $7,795,000 | -26.1% | 387,035 | -14.5% | 9.07% | -10.8% |
| ISEE | Buy | IVERIC BIO INC | $5,529,000 | -3.6% | 1,607,153 | +140.5% | 6.43% | +16.3% |
| HARP | Buy | HARPOON THERAPEUTICS INC | $5,453,000 | +199.3% | 470,926 | +282.2% | 6.34% | +261.1% |
| IRMD | Buy | IRADIMED CORP | $5,013,000 | +52.4% | 234,810 | +66.8% | 5.83% | +83.8% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $4,292,000 | +26.8% | 47,800 | +52.7% | 4.99% | +53.0% |
| ZYXI | New | ZYNEX INC | $3,859,000 | – | 348,564 | +100.0% | 4.49% | – |
| DXCM | Sell | DEXCOM INC | $3,622,000 | -5.9% | 13,450 | -23.6% | 4.22% | +13.6% |
| VCEL | Buy | VERICEL CORP | $3,231,000 | +1.1% | 352,332 | +91.8% | 3.76% | +22.0% |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $3,067,000 | -22.3% | 313,900 | -8.4% | 3.57% | -6.3% |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $2,755,000 | -10.0% | 405,207 | +97.3% | 3.21% | +8.6% |
| AGN | Sell | ALLERGAN PLC | $2,586,000 | -52.5% | 14,600 | -48.8% | 3.01% | -42.7% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $2,500,000 | -28.6% | 536,497 | +17.1% | 2.91% | -13.8% |
| MSON | Buy | MISONIX INC | $2,245,000 | -32.4% | 238,333 | +33.4% | 2.61% | -18.5% |
| ZYME | Buy | ZYMEWORKS INC | $2,182,000 | +111.6% | 61,528 | +171.0% | 2.54% | +155.4% |
| ATRS | New | ANTARES PHARMA INC | $2,039,000 | – | 864,100 | +100.0% | 2.37% | – |
| ABBV | New | ABBVIE INC | $2,019,000 | – | 26,500 | +100.0% | 2.35% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $1,970,000 | – | 7,900 | +100.0% | 2.29% | – |
| AXNX | New | AXONICS MODULATION TECHNOLOG | $1,601,000 | – | 63,000 | +100.0% | 1.86% | – |
| ITMR | New | ITAMAR MED LTDsponsored ads | $1,353,000 | – | 114,865 | +100.0% | 1.57% | – |
| RFL | Buy | RAFAEL HLDGS INC | $1,142,000 | +68.9% | 89,131 | +135.0% | 1.33% | +103.8% |
| KDMN | Sell | KADMON HLDGS INC | $1,077,000 | -32.1% | 257,141 | -26.6% | 1.25% | -18.1% |
| ZFGN | Buy | ZAFGEN INC | $1,038,000 | +16.4% | 1,348,399 | +67.7% | 1.21% | +40.5% |
| BIIB | Sell | BIOGEN INC | $949,000 | -57.3% | 3,000 | -60.0% | 1.10% | -48.6% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $914,000 | -64.7% | 63,254 | -32.4% | 1.06% | -57.4% |
| AXGN | Sell | AXOGEN INC | $781,000 | -65.7% | 75,050 | -41.1% | 0.91% | -58.7% |
| MLND | New | MILLENDO THERAPEUTICS INC | $778,000 | – | 147,406 | +100.0% | 0.90% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $727,000 | +123.0% | 16,300 | +139.7% | 0.85% | +169.4% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $696,000 | -48.7% | 16,400 | -26.5% | 0.81% | -38.2% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $665,000 | -63.8% | 72,000 | -61.9% | 0.77% | -56.3% |
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $563,000 | -71.6% | 17,900 | -57.5% | 0.66% | -65.8% |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $545,000 | – | 10,600 | +100.0% | 0.63% | – |
| CTSO | New | CYTOSORBENTS CORP | $538,000 | – | 69,600 | +100.0% | 0.63% | – |
| LVGO | Buy | LIVONGO HEALTH INC | $516,000 | +22.3% | 18,100 | +7.3% | 0.60% | +47.4% |
| SWAV | Buy | SHOCKWAVE MED INC | $404,000 | +70.5% | 12,185 | +125.6% | 0.47% | +105.2% |
| NVCR | New | NOVOCURE LTD | $377,000 | – | 5,597 | +100.0% | 0.44% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $375,000 | – | 11,000 | +100.0% | 0.44% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $360,000 | – | 90,000 | +100.0% | 0.42% | – |
| STAA | Sell | STAAR SURGICAL CO | $252,000 | -80.1% | 7,798 | -78.3% | 0.29% | -76.0% |
| TCRR | New | TCR2 THERAPEUTICS INC | $237,000 | – | 30,624 | +100.0% | 0.28% | – |
| PCRX | New | PACIRA BIOSCIENCES | $235,000 | – | 7,000 | +100.0% | 0.27% | – |
| SNDX | SYNDAX PHARMACEUTICALS INC | $230,000 | +25.0% | 20,980 | 0.0% | 0.27% | +51.4% | |
| ADRO | New | ADURO BIOTECH INC | $222,000 | – | 81,200 | +100.0% | 0.26% | – |
| AYTU | New | AYTU BIOSCIENCE INC | $209,000 | – | 139,600 | +100.0% | 0.24% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $197,000 | – | 19,000 | +100.0% | 0.23% | – |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $176,000 | -53.2% | 11,869 | -48.8% | 0.20% | -43.5% |
| New | INSMED INCnote 1.750% 1/1 | $150,000 | – | 180,000 | +100.0% | 0.18% | – | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $150,000 | -92.9% | 13,228 | -91.8% | 0.18% | -91.4% |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -11,400 | -100.0% | -0.22% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -10,700 | -100.0% | -0.23% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -1,500 | -100.0% | -0.23% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -8,700 | -100.0% | -0.34% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -4,900 | -100.0% | -0.37% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -6,700 | -100.0% | -0.38% | – |
| NTRA | Exit | NATERA INC | $0 | – | -13,000 | -100.0% | -0.42% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -7,600 | -100.0% | -0.44% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -11,100 | -100.0% | -0.49% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -9,008 | -100.0% | -0.64% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -34,900 | -100.0% | -0.70% | – |
| ICAD | Exit | ICAD INC | $0 | – | -94,900 | -100.0% | -0.71% | – |
| ZEAL | Exit | ZEALAND PHARMA A Ssponsored adr | $0 | – | -26,882 | -100.0% | -0.86% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -8,246 | -100.0% | -0.94% | – |
| STE | Exit | STERIS PLC | $0 | – | -8,800 | -100.0% | -1.29% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -26,400 | -100.0% | -2.04% | – |
| HUM | Exit | HUMANA INC | $0 | – | -5,800 | -100.0% | -2.05% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -164,600 | -100.0% | -2.41% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -226,700 | -100.0% | -6.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.